Inception Growth Acqustn Stock Price, News & Analysis

Inception Growth Acquisition Limited (warrants trading under the symbol IGTAW) is a special purpose acquisition company, or SPAC. According to its SEC filings, the company was formed to complete a business combination and has structured its capital into units, common stock, rights and redeemable warrants that trade separately. The warrants represented by IGTAW are described in regulatory disclosures as redeemable warrants, each exercisable for one share of common stock at a specified exercise price.

Inception Growth Acquisition Limited’s securities, including the units, common stock, rights and warrants, were originally listed on Nasdaq in connection with its initial public offering. The company’s definitive proxy statement states that its units, shares of common stock, rights and warrants were listed on Nasdaq as of the closing of the IPO. The same filing explains that, after the company did not complete an initial business combination within the period required by Nasdaq Interpretive Material IM-5101-2, Nasdaq determined that its securities were subject to delisting.

The proxy statement further notes that the company received a notice from Nasdaq stating that it did not comply with IM-5101-2 and that its securities were subject to delisting. The company did not appeal Nasdaq’s determination. As a result, the company’s securities were suspended from trading on Nasdaq at the opening of business on December 17, 2024. On that same date, the filings state that the company’s securities commenced trading on the OTC Markets under their prior Nasdaq trading symbols, and it is expected in those materials that the securities would continue to trade on the OTC Markets.

Multiple Form 8-K filings describe how Inception Growth Acquisition Limited has repeatedly extended the time it has available to complete a business combination by making deposits into a trust account. For example, an 8-K dated November 13, 2025 reports that on November 10, 2025 the company deposited funds into the trust account to extend the deadline to complete a business combination from November 13, 2025 to December 13, 2025. Similar 8-K filings dated December 10, 2025 and January 15, 2026 report additional deposits to extend the deadline further, ultimately to February 13, 2026.

The company’s definitive proxy statement dated September 16, 2025 details a series of prior stockholder approvals and amendments to its amended and restated certificate of incorporation and its investment management trust agreement. These amendments allowed the company to extend the date by which it must consummate a business combination and to extend the date on which it would otherwise commence liquidating the trust account. The filing outlines multiple prior extensions approved at stockholder meetings and the corresponding deposits made into the trust account for each extension period.

According to the same proxy statement, Inception Growth Acquisition Limited is incorporated in Delaware and describes itself as an emerging growth company under applicable SEC rules. The filings list its principal executive office in New York, New York. The company’s Form 12b-25 (Notification of Late Filing) for its Quarterly Report on Form 10-Q for the period ended September 30, 2025 states that it was unable, without unreasonable effort or expense, to file the Form 10-Q by the prescribed due date due to a delay in completing its financial statements, and that it anticipated filing within the extension period allowed by the rule.

For investors researching IGTAW, it is important to understand that this symbol represents redeemable warrants of Inception Growth Acquisition Limited, rather than common stock. The warrants are described in SEC filings as each being exercisable for one share of common stock at an exercise price of $11.50. The broader capital structure also includes units (each consisting of one share of common stock, one-half of one redeemable warrant and one right entitling the holder to receive one-tenth of a share of common stock), common stock trading under the symbol IGTA, and rights trading under the symbol IGTAR, all quoted as trading on OTC Markets Group, Inc. in the company’s 8-K disclosures.

The company’s proxy materials also describe the regulatory context for its extensions. Nasdaq IM-5101-2 requires a SPAC to complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Inception Growth Acquisition Limited’s filings state that this date was December 8, 2024 for the company. Because it did not complete a business combination by that date, it did not comply with IM-5101-2, leading to the Nasdaq notice and subsequent suspension and delisting of its securities from that exchange, followed by quotation on the OTC Markets.

In summary, IGTAW is tied to the warrant component of Inception Growth Acquisition Limited’s capital structure. The company’s SEC filings focus on its status as a SPAC seeking to complete a business combination, the series of extensions obtained through stockholder approvals and trust account deposits, and the transition of its securities from Nasdaq to OTC Markets following non-compliance with Nasdaq’s SPAC completion timeline rule.